# Call to Action – New consortium will use artificial intelligence technology to conduct large-scale analysis of brain changes in Huntington’s disease

21 Sep 22

news

# Call to Action – New consortium will use artificial intelligence technology to conduct large-scale analysis of brain changes in Huntington’s disease

Huntingtons Disease

CHDI

HD-IH

[  ](https://x.com/intent/tweet?url=https://ixico.com/news-and-resources/news/call-to-action-new-consortium-will-use-artificial-intelligence-technology-to-conduct-large-scale-analysis-of-brain-changes-in-huntingtons-disease/) [  ](https://bsky.app/intent/compose?text=https://ixico.com/news-and-resources/news/call-to-action-new-consortium-will-use-artificial-intelligence-technology-to-conduct-large-scale-analysis-of-brain-changes-in-huntingtons-disease/) [  ](https://www.facebook.com/sharer/sharer.php?u=https://ixico.com/news-and-resources/news/call-to-action-new-consortium-will-use-artificial-intelligence-technology-to-conduct-large-scale-analysis-of-brain-changes-in-huntingtons-disease/) [  ](https://www.linkedin.com/shareArticle?mini=true&url=https://ixico.com/news-and-resources/news/call-to-action-new-consortium-will-use-artificial-intelligence-technology-to-conduct-large-scale-analysis-of-brain-changes-in-huntingtons-disease/) <a class="trigger-share-window d-md-none">  </a>

Published on: September 21, 2022

View the full News here; [Call to Action – New consortium will use artificial intelligence technology to conduct large-scale analysis of brain changes in Huntington’s disease](https://chdifoundation.org/call-to-action-new-consortium-will-use-artificial-intelligence-technology-to-conduct-large-scale-analysis-of-brain-changes-in-huntingtons-disease/)

About IXICO \| Advanced Analytics \| Intelligent Insights.

IXICO is dedicated to delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's, Parkinson's, Alzheimer's disease and Multiple Sclerosis. The Company's purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience by supporting pharmaceutical companies across all phases of CNS clinical research. IXICO's goal is to be a leading advocate of artificial intelligence in medical image analysis.

IXICO has developed and deployed breakthrough machine learning Ai data analytics, at scale, through its remote access TrialTracker technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for the Company's pharmaceutical clients.

More information is available on [www.IXICO.com](http://www.IXICO.com) and follow us on Twitter @IXICOnews

[ Back to News  ](/news-and-resources/news/)

### Recents

![IXICO announces £2.7 million Phase 3 contract win in Huntington’s disease](/assets/blog-images/HD-contract-win__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp)

2 Nov 26

news

[IXICO announces £2.7 million Phase 3 contract win in Huntington’s disease](/news-and-resources/news/2-7-million-phase-3-contract-win-in-huntingtons-disease/)

[IXICO presents research on novel methods to reduce unwanted variability in Huntington’s disease biomarker data ](/news-and-resources/news/ixico-presents-research-on-novel-methods-to-reduce-unwanted-variability-in-huntingtons-disease-biomarker-data/)

[IXICO announces two contracts in Alzheimer's disease worth £1.5 million](/news-and-resources/news/ixico-announces-two-contracts-in-alzheimers-disease-worth-1-5-million/)

[IXICO announces 28% expected revenue growth for FY26](/news-and-resources/news/ixico-trading-update-for-year-ending-30-september-2026/)

[IXICO to present advancements in neuroimaging for Parkinson’s disease at European radiology conference ](/news-and-resources/news/ixico-to-present-advancements-in-neuroimaging-for-parkinsons-disease/)

### Library

[November 2026](/news-and-resources/news/archive/2026/11/)

[October 2026](/news-and-resources/news/archive/2026/10/)

[September 2026](/news-and-resources/news/archive/2026/09/)

[July 2026](/news-and-resources/news/archive/2026/07/)

[June 2026](/news-and-resources/news/archive/2026/06/)

[May 2026](/news-and-resources/news/archive/2026/05/)

[April 2026](/news-and-resources/news/archive/2026/04/)

[March 2026](/news-and-resources/news/archive/2026/03/)

[February 2026](/news-and-resources/news/archive/2026/02/)

[January 2026](/news-and-resources/news/archive/2026/01/)

[2025](/news-and-resources/news/archive/2025/)

[2024](/news-and-resources/news/archive/2024/)

[2023](/news-and-resources/news/archive/2023/)

[2022](/news-and-resources/news/archive/2022/)

[2021](/news-and-resources/news/archive/2021/)

[2020](/news-and-resources/news/archive/2020/)

[2019](/news-and-resources/news/archive/2019/)
